Description
Long Description:
Dapawalk-M 10/500 (SR) Tablets is a trusted antidiabetic formulation offered by Biophar Lifesciences Pvt. Ltd. It contains Dapagliflozin 10mg and Metformin Hydrochloride (Sustained Release) 500mg, designed to provide long-lasting blood glucose control in patients with Type 2 Diabetes Mellitus.
-
Dapagliflozin helps reduce glucose reabsorption by the kidneys, promoting glucose excretion through urine.
-
Metformin SR improves insulin sensitivity and reduces hepatic glucose production.
This synergistic combination not only manages blood sugar levels effectively but also supports weight control and cardiovascular benefits. Ideal for monotherapy or combination therapy protocols. Each strip contains 10×10 ALU-ALU tablets and is priced at an affordable MRP ₹165/-.
Promotional Paragraph (for Franchise & Third-Party Manufacturing):
Dapawalk-M 10/500 (SR) is a high-demand product in diabetes care and a great addition to any pharmaceutical business portfolio. With Biophar Lifesciences’ WHO-GMP certified facilities and transparent processes, you can confidently expand your reach through PCD Pharma Franchise or Third-Party Manufacturing. Our dedicated customer support, timely dispatch, and quality packaging ensure you stay ahead in the highly competitive diabetic segment. Partner with Biophar to grow with trust, quality, and innovation.
